BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mycell Technologies Announces $10 Million Institutional Financing


7/26/2012 7:28:36 AM

PARAMUS, N.J., July 26, 2012 /PRNewswire/ -- Mycell Technologies LLC, a leading intellectual property and investment holding company, specializing in the development of proprietary liquid formulations of stable, highly concentrated omega-3s for use in food, beverage, medical and nutritional products, announced today the closing of an institutional non-controlling minority investment providing Mycell Technologies with an infusion of $10 million. Terms of the transaction and investor names were not disclosed.

"We are now positioned for extraordinary growth at Mycell Technologies and Oceans Omega, our flagship ingredient subsidiary," said Benjamin D. Mamola, Chairman and Chief Executive Officer. "We are thankful to have a strategic institutional investor to share in this growth. In the coming weeks, we will be announcing additions to our management team and new partnerships to help continue our strong momentum."

About Mycell Technologies LLC (www.mycelltechnologies.com)

Mycell Technologies LLC is a leading intellectual property and investment holding company, creating proprietary liquid formulations of shelf-stable highly concentrated omega-3s.

About Oceans Omega LLC (www.oceansomega.com)

Oceans Omega LLC, a wholly-owned subsidiary of Mycell Technologies LLC, is one of the largest suppliers of stabilized omega-3 EPA/DHA ingredients to the food and beverage markets. Oceans Omega's liquid ingredient solutions represent exceptional advancements for incorporating and stabilizing omega-3 EPA/DHAs in food and beverages. Oceans Omega's unique stabilization and delivery technologies provide the purest, most stable omega-3 ingredients and lead the competition in every category. Oceans Omega's corporate offices are located in Paramus, New Jersey with manufacturing facilities in the Midwest.

Press Contact:

Stephanie Perine
Mycell Technologies LLC
sperine@mycelltechnologies.com

SOURCE Mycell Technologies LLC



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES